Dataset from A 12-week Treatment, Multi-center, Randomized, Double-blind, Parallel-group, Placebo and Active Controlled Study to Assess the Efficacy, Safety, and Tolerability of Indacaterol Maleate / Glycopyrronium Bromide in COPD Patients With Moderate to Severe Airflow Limitation.
收藏NIAID Data Ecosystem2026-05-10 收录
下载链接：
https://doi.org/10.25934/PR00012243
下载链接
链接失效反馈官方服务：
资源简介：
This study will assess the efficacy, safety and tolerability of QVA149 in patients with moderate to severe airflow limitation.
创建时间：
2025-12-16
